
United States · Research startup
Harae Dx is a medical diagnostics company focused on early cancer detection, particularly breast cancer.
Funding reportedLast round: Series A
Follow Harae Dx Corp. and see its new rounds in your feed.Start following
Harae Dx is a medical diagnostics company focused on early cancer detection, particularly breast cancer.
Founded by Rick Deckard, who has over 35 years of entrepreneurial experience, the company combines the expertise of entrepreneurs, engineers, and researchers with extensive backgrounds in AI and related fields. The company's main product is an automated cancer detection system that is compact, portable, low-cost, and rapid. This system utilizes a proprietary technology platform to efficiently detect cancer biomarkers. Harae Dx has developed the world's first portable early breast cancer test, leveraging an exclusively-licensed panel of biomarkers from Lawrence Livermore National Labs. The system is designed to be automated, cost-efficient, accurate, and user-friendly. Harae Dx is headquartered in Pleasanton, California.
Funding, as reported
From Harae Dx Corp.'s own website: 2 founders, 10 on the team.
What they build
Known for
health carerapid biomarker analysisdigital healthbiomarker-based diagnosticsmolecular diagnosticsbiotechnology researchrapid testingenterprisesbiomarker panel licensingmedical researchbiomarker detectioninformation technology & servicesenterprise softwarehospital & health careai-powered cancer diagnosticsmedical ai
Built with from their website
Amazon CloudFrontLiteSpeedWordPress.orgHostinger CDNWOWSpiceThemes SpicePressFont AwesomeCloudFlareViewport MetaWebflow Hosting
Google Font APIMySQLHostingerMobile FriendlyBootstrapjQueryHTTP/3Animate.css
Add your raise, your deck and your story, and put Harae Dx Corp. in front of investors. Or tell us what we have wrong.